Led the Natureral productshybrid researcher lab at Georgia State for 7 years on antibiotic activity against antimicrobial resistant bacteria, quorum sensing, and quorum sensing inhibition -- at it's height she had 21 researchers at 1 time
PhD Dissertation on Quorum Sensing and Antibiotic Resistance Microbials- focused on bacterial communication and Antimicrobial Resistance (AMR)
Founded QXD on a vision for bringing quorum sensing diagnostics to the forefront of healthcare and industry to reduce risks associated with microbial infection and contamination
Assembled the QXD team of functional experts in microbial science, business growth, new product development, supply chain management, and operational excellence
DR. ANGEL RIVERA - CTO
MD/PhD with an emphasis in Biochemistry/Oncology/Immunology
Over 25 years experience in medical research and product development
Authored 90 research publications
Inventor of Modified Replicative Adenoviruses to recognizecarcinomas used in animal studies
Holds three patents for Adenovirus tropism changes
Joined QXD as co-founder in 2019
In conjunction with Dr. Nagy, built successful lateral flow prototypes for indentification of the COVID SARS virus and Pseudomonasaeruginosa
MR. MARK KOEPSEL - COO
Over 40 years of global business experience
Held executive positions in Operations & Supply Chain
Experience in LBO and Private Equity portfolio companies
Leadership in acquisitions and divestitures
Extensive background in new product development
Mentor, Advisor starting in 2020 and now active role as COO
DR. BRYAN STUBBLEFIELD - SENIOR SCIENTIST
PhD in Applied and Environmental Microbiology
Expertise in experimental design, High Pressure Liquid Chromatography, Gas Chromatography, Mass Spectroscopy, identifcation and isolation of microbial derived metabolites
Experience in quantitative structure analysis of biofilms, biofilm structure and antibiotic resistant mechanisms, and polymicrobial biofilms
12 scientific publications and presentations with emphasis in biofilms, quorum sensing and fermentation
Joined QXD in 2023 to speed development of lateral flow diagnostics for Bacterial Vaginosis and Candida albicans
MR. BILL SHWARZ - ADVISOR
Over 50 years of experience in building strategy in conjunction with organizational change and leadership
Experience in acquisitions, mergers, and divestitures
Founder of the CEO Alliance and the Center for Inspired Performance
Director of two EMBA programs on Organizational Change
Authored "The Generative Organization – From Reactive Organization Behavior to Inspired Performanceand the Generative Way"
Authored "Mastering the Multiplier Equation for Organizational Transformation"
Mentor then Advisor starting in 2020
DR. RODNEY NASH - ADVISOR
PhD in Biochemistry
Founder, CEO, and successful divestiture of Jeevan Biotech
Chief Science Officer of major laboratory equipment firm
Professor at Georgia State University
Post-Doctoral Fellow at Emory University
Provides QXD with science leadership since 2018
DR. NAVI JHITA - ADVISOR
Medical Doctor
Experienced scientist and Research Fellow at Emory University
Former Research scientist at Expression Therapeutics
Provides QXD with scientific protocols for COVIDNOW clinical trials and best practices since 2020
Extensive experience in designing and executing clinical studies
The Team
MR. ROB BRIGGS - GENERAL COUNSEL - ADVISOR
A lawyer with over 40 years of experience as a Corporate and International Attorney and General Counsel
Lived and worked in the US and abroad for both public and private equity portfolio companies
Extensive background in intellectual property protection and patents
Investor and entrepreneurial experience in startup, build, and divestiture of small businesses
Experience in acquisitions, mergers, and divestitures
Built the business and legal structure for over 17 companies in the US and abroad
Joined QXD in 2022 to provide both business and legal leadership